Bifunctional particle-filled microgel as well as preparation method and application thereof
The bifunctional microgel formed by cross-linking reaction of quinoa starch-pomegranate polyphenol nanoparticles and thiolated inulin has solved the problem of retention of starch-based nanoparticles and blood sugar fluctuations, and achieved colon targeting and resistant starch Improve the treatment of colitis and diabetes effectively.
Patent Information
- Application Number
- CN202411027643.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-29
AI Technical Summary
Existing starch-based nanoparticles are difficult to stay effectively in the intestine in drug enema treatment, affecting drug absorption and efficacy. At the same time, rapidly digested starch leads to blood sugar fluctuations, an important reason for related chronic diseases.
The cross-linking reaction of quinoa starch-pomegranate polyphenol nanoparticles with thiolated inulin to form a bifunctional particle-filled microgel. The nanoparticles were prepared by magnetic field and sonication, and the colon was formed by EDC and NHS-mediated cross-linking reaction. Targeted and glutathione-responsive microgels encapsulate quinoa starch-pomegranate polyphenol nanoparticles to increase resistant starch content.
It realizes the retention of nanoparticles in the colon, relieves colitis and reduces blood sugar, has high resistant starch content, simple gel mechanism and high safety, and is effective in treating colitis and diabetes.
Smart Images

Figure CN118948747A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biomedical materials, and in particular relates to a dual-functional particle-filled microgel and a preparation method and application thereof. Background Art
[0002] Ulcerative colitis (UC) is a typical inflammatory bowel disease characterized by immune tissue relapse and gastrointestinal inflammation, accompanied by clinical symptoms such as diarrhea, rectal bleeding and fatigue, which involve the pathogenesis of genetic susceptibility, epithelial barrier dysfunction and intestinal flora dysbiosis. Patients often need drug enema treatment to relieve symptoms. However, in practical application, drug enema often faces some challenges. The most important point is that the drug may be excreted within a short time after enema, which affects the drug retention time in the intestine and further affects the drug absorption and efficacy. Nanoparticles have become a widely used tool for enhancing the delivery of poorly water-soluble functional ingredients. In particular, starch-based nanoparticle delivery systems have been shown to be an effective strategy to improve the oral bioavailability of these ingredients.
[0003] In addition, starch is one of the essential macronutrients in the human diet and is also a major source of energy. However, the intake of rapidly digested starch can lead to a rapid increase in blood sugar after a meal, which has been shown to be an important cause of diet-related chronic diseases. Previous studies have shown that the intake of resistant starch (RS) does not cause a rapid increase in blood sugar after a meal. Therefore, the development of RS in starch staples can become a key solution to the problem of diet-related chronic diseases. Natural resistant starch RS1 is composed of starch wrapped in a cell wall constructed by crude fiber, which can effectively block amylase infiltration and reduce amylase enzymolysis, thereby increasing RS content. Based on this, RS content can be increased by preparing bionic RS1-type starch.
[0004] Therefore, how to optimize existing starch-based nanoparticles so that they can be used to relieve colitis and diabetes has long been the direction that researchers in the industry have been working towards. Summary of the invention
[0005] The main purpose of the present invention is to provide a dual-functional particle-filled microgel and a preparation method and application thereof, so as to overcome the deficiencies in the prior art.
[0006] In order to achieve the above-mentioned invention object, the technical solution adopted by the present invention includes:
[0007] One aspect of the present invention provides a method for preparing a bifunctional particle-filled microgel, comprising:
[0008] providing quinoa starch-pomegranate polyphenol nanoparticles;
[0009] Mixing inulin, water, 1-ethyl-(3-dimethylaminopropyl)carbodiimide, N-hydroxysuccinimide, and L-cysteine for cross-linking reaction to obtain thiolated inulin;
[0010] The quinoa starch-pomegranate polyphenol nanoparticles are mixed with thiolated inulin and subjected to oxidation reaction to obtain a bifunctional particle-filled microgel.
[0011] Another aspect of the present invention provides a bifunctional particle-filled microgel prepared by the aforementioned preparation method.
[0012] Another aspect of the present invention also provides the use of the aforementioned dual-functional particle-filled microgel in the preparation of a drug having the function of treating colitis or diabetes.
[0013] Another aspect of the present invention provides a drug having the function of treating colitis or diabetes, which comprises the aforementioned bifunctional particle-filled microgel.
[0014] Compared with the prior art, the technical solution of the present invention has at least the following advantages:
[0015] The present invention uses thiolated inulin microgel to encapsulate quinoa starch-pomegranate polyphenol nanoparticles to form particle-filled microgels. The quinoa starch-pomegranate polyphenol nanoparticles prepared by magnetic field treatment have a high resistant starch content, can not only treat colitis but also have the effect of lowering blood sugar; the thiolated inulin prepared by a cross-linking reaction mediated by EDC and NHS has colon targeting performance and glutathione stimulation responsiveness, is almost not released in the small intestine, and releases nanoparticles in the colon, thereby effectively alleviating colitis; and the present invention forms the thiolated inulin microgel by self-crosslinking, the method is simple, has a simple gelation mechanism and in-situ gelation performance, and compared with other chemically cross-linked microgels, the microgel of the present invention has fewer by-products and higher safety. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0017] Figure 1a This is a comparison diagram of the effects of the samples prepared in Example 1 of the present invention and Comparative Examples 1-3 on the length of the mouse colon;
[0018] Figure 1b This is a comparison diagram of the effects of the samples prepared in Example 1 of the present invention and Comparative Examples 1-3 on the weight-to-length ratio of mouse colon;
[0019] Figure 2a This is a comparison diagram of the effects of the samples prepared in Example 1 of the present invention and Comparative Examples 1-3 on the secretion of inflammatory cytokine TNF-α in colitis mice;
[0020] Figure 2b This is a comparison diagram of the effects of the samples prepared in Example 1 of the present invention and Comparative Examples 1-3 on the secretion of inflammatory cytokine IL-1β in colitis mice;
[0021] Figure 2c This is a comparison diagram of the effects of the samples prepared in Example 1 of the present invention and Comparative Examples 1-3 on the secretion of inflammatory cytokine IL-6 in colitis mice;
[0022] Figure 2d This is a comparison diagram of the effects of the samples prepared in Example 1 of the present invention and Comparative Examples 1-3 on the secretion of inflammatory cytokine IL-10 in colitis mice;
[0023] Figure 3 This is a comparison chart of the effects of the samples prepared in Example 1 of the present invention and Comparative Examples 1-3 on the area under the blood glucose curve (AUC) level of diabetic mice. DETAILED DESCRIPTION
[0024] In view of the above problems existing in the prior art, the inventors of this case have conducted extensive and in-depth research and provided a dual-functional particle-filled microgel and a preparation method thereof.
[0025] The inventors of this case have found that microgels are deformable soft porous three-dimensional microscopic particles with a stable structure of cross-linked biopolymer molecules due to covalent bonds and strong non-covalent interactions. Microgels have reversible swelling properties in response to environmental changes, providing unique opportunities for oral delivery. Therefore, designing a new delivery system that combines their advantages is expected to provide the bilateral advantages of nanoparticles and microgels.
[0026] Furthermore, the inventors of this case also found that starch-based particle-filled microgels can encapsulate starch nanoparticles in a microgel matrix, which can be used as a bionic RS1-type starch to increase the resistant starch content and relieve diabetes.
[0027] Based on this, the inventors of this case designed a dual-functional particle-filled microgel that can be used to relieve colitis and diabetes, and provide a theoretical basis for tailored intervention and precise nutrition for specific populations.
[0028] The technical solution, its implementation process and principle will be further explained as follows. However, it should be understood that the specific embodiments disclosed below are only exemplary of the present invention, and the present invention can be embodied in various forms. Therefore, the specific functional details disclosed herein should not be interpreted as limiting, but only as the basis of the claims and as a representative basis for teaching those skilled in the art to adopt the present invention in different ways in any appropriate detailed embodiment.
[0029] As one aspect of the technical solution of the present invention, a method for preparing a bifunctional particle-filled microgel includes:
[0030] providing quinoa starch-pomegranate polyphenol nanoparticles;
[0031] Mixing inulin, water, 1-ethyl-(3-dimethylaminopropyl)carbodiimide (EDC), N-hydroxysuccinimide (NHS), and L-cysteine for cross-linking reaction to obtain thiolated inulin;
[0032] The quinoa starch-pomegranate polyphenol nanoparticles are mixed with thiolated inulin and subjected to oxidation reaction to obtain a bifunctional particle-filled microgel.
[0033] It should be noted that EDC is used to activate inulin molecules, NHS is used to amidate inulin molecules, and the role of L-cysteine is to thiolate inulin so that the inulin molecules carry thiol groups, so that the free sulfhydryl groups in the thiolated inulin can produce disulfide bonds through oxidation reaction, thereby completing the self-cross-linking reaction to obtain a gel.
[0034] The present invention adopts EDC and NHS-mediated cross-linking reaction to prepare thiolated inulin. The thiolated inulin not only has colon targeting, but also has glutathione stimulation responsiveness due to the presence of disulfide bonds.
[0035] In some embodiments, the method for preparing the quinoa starch-pomegranate polyphenol nanoparticles comprises: mixing pomegranate polyphenols with a quinoa starch solution, subjecting the solution to magnetic field treatment to obtain a quinoa starch-pomegranate polyphenol complex solution, and then subjecting the solution to ultrasonic treatment to obtain quinoa starch-pomegranate polyphenol nanoparticles. The quinoa starch-pomegranate polyphenol nanoparticles prepared by magnetic field treatment have a high resistant starch content, and can not only treat colitis but also have a blood sugar lowering effect.
[0036] In some preferred embodiments, the quinoa starch solution comprises quinoa starch and water, and the concentration of quinoa starch in the quinoa starch solution is 2.5-5 w / v%.
[0037] In some preferred embodiments, the mass ratio of pomegranate polyphenols to quinoa starch is 1:5-1:20.
[0038] In some preferred embodiments, the magnetic field intensity of the magnetic field treatment is 5-20 T. If the magnetic field intensity is too strong, the ordered structure of the formed quinoa starch-pomegranate polyphenol complex will be reduced.
[0039] In some preferred embodiments, the magnetic field treatment time is 1-5 hours.
[0040] In some preferred embodiments, the ultrasonic power of the ultrasonic treatment is 100-500 W. Too strong ultrasonic power will destroy the structure of starch and increase digestibility.
[0041] In some preferred embodiments, the ultrasonic treatment time is 10-60 min.
[0042] In some embodiments, the method for preparing quinoa starch-pomegranate polyphenol nanoparticles includes: adding pomegranate polyphenol to a quinoa starch solution and stirring to mix evenly, then placing in a magnetic field culture device for reaction, and after the reaction is completed, obtaining a quinoa starch-pomegranate polyphenol complex solution.
[0043] In some embodiments, the preparation method comprises: adjusting the pH value of the quinoa starch-pomegranate polyphenol complex solution to 6-9, and then performing ultrasonic treatment to obtain the quinoa starch-pomegranate polyphenol nanoparticles.
[0044] In some embodiments, the preparation method comprises: uniformly mixing an inulin aqueous solution, 1-ethyl-(3-dimethylaminopropyl)carbodiimide, and N-hydroxysuccinimide, and then adding L-cysteine to perform a cross-linking reaction to obtain the thiolated inulin.
[0045] In some preferred embodiments, the concentration of the aqueous inulin solution is 1-5 w / v%.
[0046] In some preferred embodiments, the added amount of 1-ethyl-(3-dimethylaminopropyl)carbodiimide is 0.1-1 w / w% (based on the mass of inulin).
[0047] In some preferred embodiments, the added amount of N-hydroxysuccinimide is 0.1-1 w / w% (based on the mass of inulin).
[0048] In some preferred embodiments, the mass ratio of inulin to L-cysteine is 20:1-2:1.
[0049] In some embodiments, the preparation method specifically includes: dissolving inulin in water, then adding EDC and NHS to obtain a mixture, stirring the mixture at room temperature for 15-30 minutes, then adding L-cysteine, adjusting the pH value to 5.0-6.0, and stirring at room temperature at a speed of 200-500 rpm for 1-3 hours to complete the cross-linking reaction.
[0050] In some embodiments, the preparation method includes: adding the quinoa starch-pomegranate polyphenol nanoparticles to a thiolated inulin solution, and then exposing the nanoparticles to the air at room temperature for reaction for 1-3 hours (during this process, the free thiol groups in the thiolated inulin generate disulfide bonds through oxidation reaction, thereby completing a self-crosslinking reaction to obtain a gel), completing the self-crosslinking of the free thiol groups, and obtaining the bifunctional particle-filled microgel.
[0051] In some preferred embodiments, the mass ratio of the quinoa starch-pomegranate polyphenol nanoparticles to the thiolated inulin is 1:2-1:10.
[0052] In some preferred embodiments, the thiolated inulin solution is obtained by mixing the thiolated inulin with phosphate buffered saline (PBS).
[0053] In some more preferred embodiments, the concentration of the thiolated inulin solution is 2.5-5 w / v%.
[0054] In some more preferred embodiments, the pH value of the phosphate buffer is 7-8.
[0055] In some more specific embodiments, the preparation method comprises:
[0056] S1: adding pomegranate polyphenols to quinoa starch solution and stirring evenly, placing the mixed solution in a magnetic field incubator and reacting with stirring for a specific time to obtain a quinoa starch-pomegranate polyphenol complex solution, then adjusting the pH value of the quinoa starch-pomegranate polyphenol complex solution to 6-9, and performing ultrasonic treatment using a probe ultrasonic instrument to obtain quinoa starch-pomegranate polyphenol nanoparticles;
[0057] S2: Dissolve inulin in sterile water, add appropriate amounts of EDC and NHS for activation and amidation of inulin, and stir the mixture at room temperature for 15-30 minutes, then add L-cysteine, adjust the pH value of the mixture to 5.0-6.0, and stir at room temperature at a speed of 200-500 rpm for 1-3 hours to complete the cross-linking reaction between L-cysteine and inulin to form thiolated inulin;
[0058] S3: Dissolve the thiolated inulin in PBS (pH=8) to form a thiolated inulin solution, add quinoa starch-pomegranate polyphenol nanoparticles to the thiolated inulin solution, and expose the mixed solution to air at room temperature for 1-3 hours to complete the self-crosslinking of the free thiol groups to obtain a bifunctional particle-filled microgel.
[0059] As another aspect of the technical solution of the present invention, it also relates to a bifunctional particle-filled microgel prepared by the aforementioned preparation method.
[0060] As another aspect of the technical solution of the present invention, it also involves the use of the aforementioned dual-functional particle-filled microgel in the preparation of a drug having the function of treating colitis or diabetes.
[0061] As another aspect of the technical solution of the present invention, it also relates to a drug having the function of treating colitis or diabetes, which comprises the aforementioned dual-functional particle-filled microgel.
[0062] In summary, the present invention prepares quinoa starch-pomegranate polyphenol complex by magnetic field treatment, and further prepares quinoa starch-pomegranate polyphenol nanoparticles by ultrasonic induction; then disperses L-cysteine in inulin solution, and forms thiolated inulin through cross-linking reaction mediated by EDC and NHS; finally, disperses quinoa starch-pomegranate polyphenol nanoparticles in thiolated inulin solution, and forms self-cross-linked particle-filled microgel through oxidation reaction of free thiols. The dual-functional particle-filled microgel for relieving colitis and diabetes obtained by the above technical solution of the present invention provides a new method for effectively relieving colitis and diabetes.
[0063] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The reagents and raw materials used in the following examples are commercially available, and the experimental methods without specific conditions are usually carried out under conventional conditions or under conditions recommended by the manufacturers.
[0064] Example 1
[0065] (1) Preparation of quinoa starch-pomegranate polyphenol nanoparticles
[0066] 5g of quinoa starch was added to 100mL of ultrapure water to prepare a 5w / v% quinoa starch solution. 1g of pomegranate polyphenols was added to the above solution, and it was placed in an incubator with a magnetic field strength of 15T and stirred for 5h to obtain a quinoa starch-pomegranate polyphenol complex solution. The quinoa starch-pomegranate polyphenol complex solution was then adjusted to a pH of 7.5, and ultrasonic waves were applied at a power of 500W for 50min to obtain quinoa starch-pomegranate polyphenol nanoparticles.
[0067] (2) Preparation of thiolated inulin
[0068] 2.5 g of inulin was dissolved in 100 mL of sterile water, followed by the addition of 0.1% (based on the mass of inulin) of EDC and 0.1% (based on the mass of inulin) of NHS for activation and amidation of inulin, and the mixture was stirred at room temperature for 15 min. 1.0 g of L-cysteine was added, the pH was adjusted to 5.0, and the mixture was stirred at 300 rpm for 3 h to complete the cross-linking reaction between L-cysteine and inulin to form thiolated inulin.
[0069] (3) Preparation of particle-filled microgels
[0070] 2.5 g of thiolated inulin was dissolved in 100 mL of PBS (pH = 8) to form a thiolated inulin solution, and 0.45 g of quinoa starch-pomegranate polyphenol nanoparticles were dispersed in the thiolated inulin solution. The above solution was exposed to air at room temperature for 1 h to complete the self-crosslinking of free thiol groups to form particle-filled microgels.
[0071] Example 2
[0072] (1) Preparation of quinoa starch-pomegranate polyphenol nanoparticles
[0073] 5g of quinoa starch was added to 100mL of ultrapure water to prepare a 5w / v% quinoa starch solution. 0.25g of pomegranate polyphenols was added to the above solution, and it was placed in an incubator with a magnetic field strength of 5T and stirred for 1h to obtain a quinoa starch-pomegranate polyphenol complex solution. The quinoa starch-pomegranate polyphenol complex solution was then adjusted to a pH of 7.5, and ultrasonic waves were applied at a power of 100W for 10min to obtain quinoa starch-pomegranate polyphenol nanoparticles.
[0074] (2) Preparation of thiolated inulin
[0075] 2.5 g of inulin was dissolved in 100 mL of sterile water, followed by the addition of 0.1% (based on the mass of inulin) of EDC and 0.1% (based on the mass of inulin) of NHS for activation and amidation of inulin, and the mixture was stirred at room temperature for 15 min. 0.3 g of L-cysteine was added, the pH was adjusted to 5.0, and the mixture was stirred at 300 rpm for 3 h to complete the cross-linking reaction between L-cysteine and inulin to form thiolated inulin.
[0076] (3) Preparation of particle-filled microgels
[0077] 2.5 g of thiolated inulin was dissolved in 100 mL of PBS (pH = 8) to form a thiolated inulin solution, and 1.25 g of quinoa starch-pomegranate polyphenol nanoparticles were dispersed in the thiolated inulin solution. The above solution was exposed to air at room temperature for 1 h to complete the self-crosslinking of free thiol groups to form particle-filled microgels.
[0078] Example 3
[0079] (1) Preparation of quinoa starch-pomegranate polyphenol nanoparticles
[0080] 4 g of quinoa starch was added to 100 mL of ultrapure water to prepare a 4 w / v % quinoa starch solution. 0.5 g of pomegranate polyphenols was added to the above solution, and it was placed in an incubator with a magnetic field strength of 10 T and stirred for 2 h to obtain a quinoa starch-pomegranate polyphenol complex solution. The quinoa starch-pomegranate polyphenol complex solution was then adjusted to a pH of 7.5, and ultrasonic waves were applied at a power of 200 W for 20 min to obtain quinoa starch-pomegranate polyphenol nanoparticles.
[0081] (2) Preparation of thiolated inulin
[0082] 2.5 g of inulin was dissolved in 100 mL of sterile water, followed by the addition of 0.6% (based on the mass of inulin) of EDC and 0.6% (based on the mass of inulin) of NHS for activation and amidation of inulin, and the mixture was stirred at room temperature for 15 min. 0.2 g of L-cysteine was added, the pH was adjusted to 5.0, and the mixture was stirred at 300 rpm for 3 h to complete the cross-linking reaction between L-cysteine and inulin to form thiolated inulin.
[0083] (3) Preparation of particle-filled microgels
[0084] 2.5 g of thiolated inulin was dissolved in 100 mL of PBS (pH = 8) to form a thiolated inulin solution, and 1.0 g of quinoa starch-pomegranate polyphenol nanoparticles were dispersed in the thiolated inulin solution. The above solution was exposed to air at room temperature for 1 h to complete the self-crosslinking of free thiol groups to form particle-filled microgels.
[0085] Example 4
[0086] (1) Preparation of quinoa starch-pomegranate polyphenol nanoparticles
[0087] 4.5 g of quinoa starch was added to 100 mL of ultrapure water to prepare a 4.5 w / v% quinoa starch solution. 0.75 g of pomegranate polyphenols was added to the above solution, and the solution was placed in an incubator with a magnetic field strength of 15 T and stirred for 3 h to obtain a quinoa starch-pomegranate polyphenol complex solution. The quinoa starch-pomegranate polyphenol complex solution was then adjusted to a pH of 7.5, and ultrasonic waves were applied at a power of 300 W for 30 min to obtain quinoa starch-pomegranate polyphenol nanoparticles.
[0088] (2) Preparation of thiolated inulin
[0089] 1.25 g of inulin was dissolved in 100 mL of sterile water, followed by the addition of 0.3% (based on the mass of inulin) of EDC and 0.3% (based on the mass of inulin) of NHS for activation and amidation of inulin, and the mixture was stirred at room temperature for 15 min. 0.15 g of L-cysteine was added, the pH was adjusted to 5.0, and the mixture was stirred at 300 rpm for 3 h to complete the cross-linking reaction between L-cysteine and inulin to form thiolated inulin.
[0090] (3) Preparation of particle-filled microgels
[0091] 2.5 g of thiolated inulin was dissolved in 100 mL of PBS (pH = 8) to form a thiolated inulin solution, and 0.75 g of quinoa starch-pomegranate polyphenol nanoparticles were dispersed in the thiolated inulin solution. The above solution was exposed to air at room temperature for 1 h to complete the self-crosslinking of free thiol groups to form particle-filled microgels.
[0092] Example 5
[0093] (1) Preparation of quinoa starch-pomegranate polyphenol nanoparticles
[0094] 5 g of quinoa starch was added to 100 mL of ultrapure water to prepare a 5 w / v % quinoa starch solution. 1 g of pomegranate polyphenols was added to the above solution, and it was placed in an incubator with a magnetic field strength of 20 T and stirred for 4 h to obtain a quinoa starch-pomegranate polyphenol complex solution. The quinoa starch-pomegranate polyphenol complex solution was then adjusted to a pH of 7.5, and ultrasonic waves were applied at a power of 400 W for 40 min to obtain quinoa starch-pomegranate polyphenol nanoparticles.
[0095] (2) Preparation of thiolated inulin
[0096] 2.5 g of inulin was dissolved in 100 mL of sterile water, followed by the addition of 0.25% (based on the mass of inulin) of EDC and 0.25% (based on the mass of inulin) of NHS for activation and amidation of inulin, and the mixture was stirred at room temperature for 15 min. 0.6 g of L-cysteine was added, the pH was adjusted to 5.0, and the mixture was stirred at 300 rpm for 3 h to complete the cross-linking reaction between L-cysteine and inulin to form thiolated inulin.
[0097] (3) Preparation of particle-filled microgels
[0098] 2.5 g of thiolated inulin was dissolved in 100 mL of PBS (pH = 8) to form a thiolated inulin solution, and 0.25 g of quinoa starch-pomegranate polyphenol nanoparticles were dispersed in the thiolated inulin solution. The above solution was exposed to air at room temperature for 1 h to complete the self-crosslinking of free thiol groups to form particle-filled microgels.
[0099] Example 6
[0100] (1) Preparation of quinoa starch-pomegranate polyphenol nanoparticles
[0101] 2.5 g of quinoa starch was added to 100 mL of ultrapure water to prepare a 2.5 w / v% quinoa starch solution. 0.5 g of pomegranate polyphenols was added to the above solution, and the solution was placed in an incubator with a magnetic field strength of 20 T and stirred for 4 h to obtain a quinoa starch-pomegranate polyphenol complex solution. The quinoa starch-pomegranate polyphenol complex solution was then adjusted to a pH of 6, and ultrasonic waves were applied at a power of 400 W for 60 min to obtain quinoa starch-pomegranate polyphenol nanoparticles.
[0102] (2) Preparation of thiolated inulin
[0103] 4 g of inulin was dissolved in 100 mL of sterile water, followed by the addition of 1% (based on the mass of inulin) of EDC and 1% (based on the mass of inulin) of NHS for activation and amidation of inulin, and the mixture was stirred at room temperature for 20 min. 0.2 g of L-cysteine was added, the pH was adjusted to 5.5, and the mixture was stirred at 200 rpm for 2 h to complete the cross-linking reaction between L-cysteine and inulin to form thiolated inulin.
[0104] (3) Preparation of particle-filled microgels
[0105] 4 g of thiolated inulin was dissolved in 100 mL of PBS (pH = 7) to form a thiolated inulin solution, and 0.4 g of quinoa starch-pomegranate polyphenol nanoparticles were dispersed in the thiolated inulin solution. The above solution was exposed to air at room temperature for 2 h to complete the self-crosslinking of free thiol groups to form particle-filled microgels.
[0106] Example 7
[0107] (1) Preparation of quinoa starch-pomegranate polyphenol nanoparticles
[0108] 2.5 g of quinoa starch was added to 100 mL of ultrapure water to prepare a 2.5 w / v% quinoa starch solution. 0.5 g of pomegranate polyphenols was added to the above solution, and the solution was placed in an incubator with a magnetic field strength of 20 T and stirred for 4 h to obtain a quinoa starch-pomegranate polyphenol complex solution. The quinoa starch-pomegranate polyphenol complex solution was then adjusted to a pH of 9, and ultrasonic waves were applied at a power of 400 W for 60 min to obtain quinoa starch-pomegranate polyphenol nanoparticles.
[0109] (2) Preparation of thiolated inulin
[0110] 5 g of inulin was dissolved in 100 mL of sterile water, followed by the addition of 0.15% (based on the mass of inulin) of EDC and 0.15% (based on the mass of inulin) of NHS for activation and amidation of inulin, and the mixture was stirred at room temperature for 30 min. 0.6 g of L-cysteine was added, the pH was adjusted to 6.0, and the mixture was stirred at 500 rpm for 2 h to complete the cross-linking reaction between L-cysteine and inulin to form thiolated inulin.
[0111] (3) Preparation of particle-filled microgels
[0112] 5 g of thiolated inulin was dissolved in 100 mL of PBS (pH = 7.5) to form a thiolated inulin solution, and 0.5 g of quinoa starch-pomegranate polyphenol nanoparticles were dispersed in the thiolated inulin solution. The above solution was exposed to air at room temperature for 3 h to complete the self-crosslinking of free thiol groups to form particle-filled microgels.
[0113] Comparative Example 1
[0114] Preparation of quinoa starch-pomegranate polyphenols complex
[0115] 5 g of quinoa starch was added to 100 mL of ultrapure water to prepare a 5 w / v% quinoa starch solution. 1 g of pomegranate polyphenol was added to the above solution, and the solution was placed in an incubator with a magnetic field strength of 15 T and stirred for 5 h to obtain a quinoa starch-pomegranate polyphenol complex solution.
[0116] Comparative Example 2
[0117] Preparation of quinoa starch / pomegranate polyphenols nanoparticles
[0118] 5 g of quinoa starch was added to 100 mL of ultrapure water to prepare a 5 w / v% quinoa starch solution. 1 g of pomegranate polyphenol was added to the above solution and stirred for 1 h to obtain a quinoa starch / pomegranate polyphenol mixture solution. The quinoa starch-pomegranate polyphenol mixture solution was then adjusted to a pH value of 7.5, and ultrasonic waves were applied at a power of 500 W for 50 min to obtain quinoa starch / pomegranate polyphenol nanoparticles.
[0119] Comparative Example 3
[0120] Preparation of quinoa starch-pomegranate polyphenol nanoparticles
[0121] 5 g of quinoa starch was added to 100 mL of ultrapure water to prepare a 5 w / v % quinoa starch solution. 1 g of pomegranate polyphenols was added to the above solution, and it was placed in an incubator with a magnetic field strength of 15 T and stirred for 5 h to obtain a quinoa starch-pomegranate polyphenol complex solution. The quinoa starch-pomegranate polyphenol complex solution was then adjusted to a pH of 7.5, and ultrasonic waves were applied at a power of 500 W for 50 min to obtain quinoa starch-pomegranate polyphenol nanoparticles.
[0122] Animal experiments
[0123] Animal experiments were conducted using the dual-functional particles filled microgels of Example 1, the quinoa starch-pomegranate polyphenols complex of Comparative Example 1, the quinoa starch / pomegranate polyphenols nanoparticles of Comparative Example 2, and the quinoa starch-pomegranate polyphenols nanoparticles of Comparative Example 3:
[0124] The colitis mice were treated: the mice injected with water only were used as the blank group (control), the mice group induced with DSS (dextran sulfate sodium) only (DSS) and the DSS mice group treated with pomegranate polyphenols only (PP) were used as the experimental control group. Figures 1a to 2d .
[0125] like Figure 1a and Figure 1b As shown, the colon length of the mice treated in Example 1 was significantly longer than that of the control group, and the colon weight-to-length ratio of the mice treated in Example 1 was significantly lower than that of the control group, indicating that the bifunctional particle-filled microgel has a better therapeutic effect on ulcerative colitis.
[0126] like Figure 2a , Figure 2b , Figure 2c , Figure 2d As shown, the levels of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) in the mice treated with Example 1 were significantly lower than those in the control group, and the level of anti-inflammatory cytokine (IL-10) was significantly higher than that in the control group, indicating that the bifunctional particle-filled microgel has a better therapeutic effect on ulcerative colitis.
[0127] Treatment of diabetic mice: The diabetic mice group injected with water only was used as the blank group (control1). Figure 3 .
[0128] like Figure 3 As shown, the area under the blood glucose curve (AUC) of diabetic mice treated with Example 1 was significantly lower than that of the control group, indicating that the bifunctional particle-filled microgel can better lower blood glucose levels.
[0129] In addition, the inventors of this case also referred to the aforementioned embodiments and conducted experiments with other raw materials and conditions listed in this specification, and also prepared bifunctional particle-filled microgels that can relieve colitis and diabetes, and obtained relatively ideal results.
[0130] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A method for preparing a bifunctional particle-filled microgel, characterized in that: include: providing quinoa starch-pomegranate polyphenol nanoparticles; Mixing inulin, water, 1-ethyl-(3-dimethylaminopropyl)carbodiimide, N-hydroxysuccinimide, and L-cysteine for cross-linking reaction to obtain thiolated inulin; The quinoa starch-pomegranate polyphenol nanoparticles are mixed with thiolated inulin and subjected to oxidation reaction to obtain a bifunctional particle-filled microgel.
2. The preparation method according to claim 1, characterized in that: The preparation method of quinoa starch-pomegranate polyphenol nanoparticles comprises: mixing pomegranate polyphenols with a quinoa starch solution, subjecting the mixture to magnetic field treatment to obtain a quinoa starch-pomegranate polyphenol complex solution, and then subjecting the mixture to ultrasonic treatment to obtain quinoa starch-pomegranate polyphenol nanoparticles; Preferably, the quinoa starch solution comprises quinoa starch and water, and the concentration of quinoa starch in the quinoa starch solution is 2.5-5 w / v%; Preferably, the mass ratio of pomegranate polyphenols to quinoa starch is 1:5-1:20; Preferably, the magnetic field intensity of the magnetic field treatment is 5-20T; Preferably, the magnetic field treatment time is 1-5h; Preferably, the ultrasonic power of the ultrasonic treatment is 100-500W; Preferably, the ultrasonic treatment time is 10-60 min.
3. The preparation method according to claim 2, characterized in that: The preparation method of quinoa starch-pomegranate polyphenol nanoparticles comprises: adding pomegranate polyphenol to a quinoa starch solution and stirring and mixing evenly, then placing in a magnetic field culture device for reaction, and after the reaction is completed, obtaining a quinoa starch-pomegranate polyphenol complex solution; And / or, the preparation method comprises: adjusting the pH value of the quinoa starch-pomegranate polyphenol complex solution to 6-9, and then performing ultrasonic treatment to obtain the quinoa starch-pomegranate polyphenol nanoparticles.
4. The preparation method according to claim 1, characterized in that: include: The inulin aqueous solution, 1-ethyl-(3-dimethylaminopropyl)carbodiimide and N-hydroxysuccinimide are uniformly mixed, and then L-cysteine is added to carry out a cross-linking reaction to obtain the thiolated inulin; Preferably, the concentration of the inulin aqueous solution is 1-5 w / v%; Preferably, the amount of 1-ethyl-(3-dimethylaminopropyl)carbodiimide added is 0.1-1% of the mass of inulin; Preferably, the amount of N-hydroxysuccinimide added is 0.1-1% of the mass of inulin; Preferably, the mass ratio of inulin to L-cysteine is 20:1-2:
1.
5. The preparation method according to claim 4, characterized in that: Specifically include: Inulin is dissolved in water, and then 1-ethyl-(3-dimethylaminopropyl)carbodiimide and N-hydroxysuccinimide are added to obtain a mixture, and the mixture is stirred at room temperature for 15-30 minutes, and then L-cysteine is added, and the pH value is adjusted to 5.0-6.0, and stirred at room temperature at a speed of 200-500 rpm for 1-3 hours to complete the cross-linking reaction.
6. The preparation method according to claim 1, characterized in that: include: Adding the quinoa starch-pomegranate polyphenol nanoparticles to the thiolated inulin solution, and then reacting in air at room temperature for 1-3 hours to complete the self-crosslinking of free thiol groups to obtain the bifunctional particle-filled microgel; Preferably, the mass ratio of the quinoa starch-pomegranate polyphenol nanoparticles to the thiolated inulin is 1:2-1:
10.
7. The preparation method according to claim 6, characterized in that: The thiolated inulin solution is obtained by mixing the thiolated inulin with a phosphate buffer solution; Preferably, the concentration of the thiolated inulin solution is 2.5-5 w / v%; Preferably, the pH value of the phosphate buffer is 7-8.
8. A bifunctional particle-filled microgel prepared by the preparation method according to any one of claims 1 to 7.
9. Use of the bifunctional particle-filled microgel according to claim 8 in the preparation of a drug for treating colitis or diabetes.
10. A drug for treating colitis or diabetes, characterized in that The invention comprises the bifunctional particle-filled microgel as described in claim 8.
Citation Information
Patent Citations
Bioactive polyphenol-rich quinoa soft capsule and preparation method thereof
CN106511623A
Preparation method of quinoa starch microspheres
CN111961235A
Quinoa cereal beverage with high resistant starch content and preparation method thereof
CN113598292A
Application of inulin in prevention and treatment of small intestine diseases
CN115350204A
Inulin gel loaded with polypyrrole nanoparticles and pirfenidone and application of inulin gel
CN116602913A
